|
|
|
|
LEADER |
02791nmm a2200337 u 4500 |
001 |
EB001853047 |
003 |
EBX01000000000000001017350 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
181102 ||| eng |
020 |
|
|
|a 9783319993287
|
100 |
1 |
|
|a Pham, Phuc Van
|e [editor]
|
245 |
0 |
0 |
|a Stem Cell Drugs - A New Generation of Biopharmaceuticals
|h Elektronische Ressource
|c edited by Phuc Van Pham
|
250 |
|
|
|a 1st ed. 2018
|
260 |
|
|
|a Cham
|b Springer International Publishing
|c 2018, 2018
|
300 |
|
|
|a X, 157 p. 15 illus., 12 illus. in color
|b online resource
|
505 |
0 |
|
|a Part1. Microvesicles -- Chapter1. Stem cell-derived microvesicles for regenerative medicine: A new paradigm for cell-based-cell-free therapy -- Chapter2. Secretome: Pharmaceuticals for Cell Free Regenerative Therapy -- Chapter3. Microvesicles preparation from mesenchymal stem cells -- Chapter4. Exosomes for repair, regeneration and rejuvenation -- Chapter5. Pro-inflammatory cytokines significantly stimulate extracellular vesicle production by adipose-derived and umbilical cord-derived mesenchymal stem cells -- Part2. Stem cells -- Chapter6. An evolution of stem cell products in medicine: a future of off-the-shelf products -- Chapter7. Off-the-shelf mesenchymal stem cell technology -- Chapter8. Ethical and legal issues of cord blood stem cell banking
|
653 |
|
|
|a Pharmaceutical chemistry
|
653 |
|
|
|a Regenerative Medicine and Tissue Engineering
|
653 |
|
|
|a Stem cells
|
653 |
|
|
|a Stem Cell Biology
|
653 |
|
|
|a Pharmaceutics
|
653 |
|
|
|a Regenerative medicine
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
490 |
0 |
|
|a Stem Cells in Clinical Applications
|
028 |
5 |
0 |
|a 10.1007/978-3-319-99328-7
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-99328-7?nosfx=y
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 571.6
|
082 |
0 |
|
|a 616.02774
|
520 |
|
|
|a This invaluable resource discusses the current revolution in stem cell-based drugs and their potential use in clinical applications. Each chapter is contributed by a pre-eminent scientist in the field. An introductory section presents current stem cell drugs and stem cell-based products and a discussion of production, quality control, mechanisms, and efficacy. Following sections include discussions on stem cell-derived microvesicles based products, and derived exosomes based products. Stem Cell Drugs - A New Generation of Biopharmaceuticals and the other books in the Stem Cells in Clinical Applications series are invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering. This groundbreaking volume is also essential reading for those researching or studying drug development or pharmaceutical science.
|